ENTPD1 and bladder transitional cell carcinoma: We then analyzed TCGA-BLCA data using GEPIA17, an online tool available at http://gepia.cancer-pku.cn/, and found that only CD39 was significantly associated with patient progression among all these immune checkpoints (Supplementary Fig. 1B).